-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JBK/PnHxrjHD/eKiXWl6tzO5CVTaixGaJ7m+A5QU5OUbcw8lE3dIV+fPyPjPdzCl exnSAG2B8gw9Ps64STCsdw== 0001332432-06-000015.txt : 20060206 0001332432-06-000015.hdr.sgml : 20060206 20060206141131 ACCESSION NUMBER: 0001332432-06-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060202 FILED AS OF DATE: 20060206 DATE AS OF CHANGE: 20060206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubinstein Linda M CENTRAL INDEX KEY: 0001321937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 06580919 BUSINESS ADDRESS: BUSINESS PHONE: (510) 670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-02-02 0000913275 Solexa, Inc. SLXA 0001321937 Rubinstein Linda M C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP & Chief Financial Officer Employee Stock Option (right to buy) 8.60 2006-02-02 4 A 0 75000 8.60 A 2016-02-02 Common Stock 75000 75000 D Shares will vest monthly from the vesting commencement date, February 2, 2006, over a four year period. Upon the consummation of an Asset Sale, Merger, Consolidation or Reverse Merger, each as defined in the Company's 2005 Equity Incentive Plan, the vesting shall be accelerated by two years in accordance with the terms of that certain letter agreement dated March 23, 2005, by and between the Company and Optionholder. /s/ Linda Rubinstein 2006-02-06 -----END PRIVACY-ENHANCED MESSAGE-----